Trialect

Verified

Minority Career Development Award (CDA) in Lung Cancer

Lung Cancer Research Foundation

Program Summary National Institutes of Health (NIH) funding is considered a prerequisite for establishing independence, academic promotion, recognition as an expert, serving on grant review panels, and leadership roles. Minority applicants are less likely to receive grants, to have the R phases of K01 or K99 awards activated, need more submissions to obtain funding, and often will not resubmit proposals.1-5 As minority applicants must overcome systemic and structural barriers due to race, ethnicity, country of origin, socioeconomic status, and/or language, many leave academia which further exacerbates the lack of diversity in Science, Technology, Engineering and Mathematics (STEM) and medical fields. To provide protected time and mentoring to these trainees, we continue to offer the LCRF Minority Career Development Award (CDA) for Lung Cancer for minority Postdoctoral/Clinical Fellows and Assistant Professors within 10 years of completing their MD training and/or PhD degrees to submit proposals.

The LCRF Minority Career Development Award (CDA) for Lung Cancer is a two-year career development award intended to support early-stage scientists from underrepresented groups working in lung cancer and working in diverse areas of research including basic, clinical, translational, disparities, and social determinants of health research. The objective of this award is to increase the number of highly skilled and trained researchers from groups that are historically underrepresented in academia, medicine, and leadership in lung cancer research. This program aims to close the gap between the mortality rates and representation in lung cancer research by funding minority researchers with $150,000 over a period of two years

We encourage applications on a wide variety of topics including but not limited to the following:

• Lung cancer biology

• Risk reduction and screening for early detection

• Identification of new biomarkers

• Development of more effective and less toxic therapies including but not limited to targeted and immunetherapies

• Genetic and gene-environment interactions

• Interactions and contributions of multiple factors (e.g. smoking, genetics, environment, societal factors) to disparities in lung cancer outcomes

• Mechanisms of sensitivity and resistance to lung cancer therapies

• Bioengineering approaches to understanding and/or treating lung cancer (i.e., theranostics, biomaterials, nanotechnology, controlled-drug release, and gene-therapy)

• Supportive measures for people with lung cancer and their families

• Identification of metabolic vulnerabilities in lung cancer

Budget Requirements

The maximum award amount is $150,000 for a period of two years (disbursed at $75,000 per year). Additional budget requirements are:

• Funding from this award may not be used to support institutional indirect / facilities and administrative costs.

• The LCRF grant must be the primary source of support for the project. Additional secondary funding (e.g. for core services support) is permitted.

• There is no limit on the amount of salary support that may be requested. However, appropriate justification for all budget items is required. Any salary requests totaling in excess of 20% of the budget must be explicitly justified.

• Any equipment costs must be limited and directly applicable to the research project (i.e. large, general equipment costs are not permitted).

• Direct patient care costs that could be reimbursed by other sources will not be covered.

• Travel and publication costs are permitted.

Specialties

Cancer

Immunology

Oncology

Pathology

Cell Biology

Molecular Biology

Others

Pulmonology

Eligibility Requirements

Investigators must be from racial or ethnic groups that are underrepresented in health-related sciences and biomedical research.This includes Blacks or African Americans, Hispanics or Latinos, American Indians or Alaskan Natives, Native Hawaiians and other Pacific Islanders. Individuals from racial or ethnic groups that can demonstrate convincingly that they are underrepresented by the host institution will also be eligible. 1 Investigators will need to fill out demographic information and provide a short statement from their Institution indicating their eligibility. Investigators must be affiliated with a non-profit academic or research institution and must be post-doctoral researchers, clinical fellows, or early-career and mid-career investigators within 10 years of receiving their MD and/or Ph.D. However, exceptions will be made for investigators with more than ten years’ experience in other disease areas or topics. Exceptions may also be made for those who did training outside the US.

Applicants from US-based and international institutions are eligible to apply and may hold any residency/citizenship status. Applicants may only apply for one LCRF grant per grant cycle. Applicants are prohibited from applying if they have received funding from the LCRF within the last 4 years. Ineligible investigators with these or other special circumstances may request review by contacting the LCRF grants office (see Inquiries section below).

Sponsor Details

Sponsor Institute/Organizations: Lung Cancer Research Foundation

Sponsor Type:

Address: 501 7th Avenue, Suite 401 New York, NY 10018 United States

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity